257 filings
S-3/A
PLSE
Pulse Biosciences Inc
Shelf registration (amended)
15 Apr 24
9:56am
EFFECT
PLSE
Pulse Biosciences Inc
9 Apr 24
Notice of effectiveness
12:15am
S-3
PLSE
Pulse Biosciences Inc
Shelf registration
3 Apr 24
5:20pm
8-K
PLSE
Pulse Biosciences Inc
28 Mar 24
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
4:18pm
S-3
PLSE
Pulse Biosciences Inc
Shelf registration
28 Mar 24
4:11pm
8-K
gj10dfawu5czn1vba
11 Mar 24
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
9:10am
8-K
452h02 cjkzgpr
14 Feb 24
Other Events
9:22am
8-K
t64ig 35zv
9 Jan 24
Regulation FD Disclosure
9:20am
8-K
mj7aqm7f
2 Jan 24
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
9:20am
8-K
bfu4ztcoue01e
22 Dec 23
Submission of Matters to a Vote of Security Holders
9:08am
8-K
9i04ma1kr
20 Dec 23
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
9:06am
8-K
kjj9fsipwd9ucn6b2i
27 Nov 23
Regulation FD Disclosure
9:08am
8-K
uj3fmex2 l2ab
21 Nov 23
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
9:03am
8-K
r4kdtmyksxapv7c
13 Nov 23
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
9:12am
8-K
n3rdfcbc8kp7 794w
12 Sep 23
Departure of Directors or Certain Officers
9:15am
EFFECT
85jrwu83w41 znlx
31 Aug 23
Notice of effectiveness
12:15am